| Authors: |
Marelli S; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Williamson JC; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Protasio AV; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Naamati A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Greenwood EJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Deane JE; Department of Clinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, United Kingdom., Lehner PJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom., Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom. |
